Ascelia Pharma AB (publ) ACE.ST Stock
9.44 SEK
{{ price }}
-0.631583%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
318.67M SEK
LOW - HIGH [24H]
9.29
-
9.8 SEK
VOLUME [24H]
102.82K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-2.66 SEK
Ascelia Pharma AB (publ) Price Chart
Ascelia Pharma AB (publ) ACE.ST Financial and Trading Overview
| Ascelia Pharma AB (publ) stock price | 9.44 SEK |
| Previous Close | 16.5 SEK |
| Open | 16.5 SEK |
| Bid | 15.9 SEK x 0 |
| Ask | 15.98 SEK x 0 |
| Day's Range | 16 - 16.5 SEK |
| 52 Week Range | 13.5 - 27.45 SEK |
| Volume | 72.34K SEK |
| Avg. Volume | 29.38K SEK |
| Market Cap | 556.43M SEK |
| Beta (5Y Monthly) | 0.76768 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.66 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.5 SEK |
ACE.ST Valuation Measures
| Enterprise Value | 448.38M SEK |
| Trailing P/E | N/A |
| Forward P/E | -7.272727 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.8563507 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.951 |
Trading Information
Ascelia Pharma AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.76768 |
| 52-Week Change | -19.99% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27.45 SEK |
| 52 Week Low | 13.5 SEK |
| 50-Day Moving Average | 15.18 SEK |
| 200-Day Moving Average | 17.19 SEK |
ACE.ST Share Statistics
| Avg. Volume (3 month) | 29.38K SEK |
| Avg. Daily Volume (10-Days) | 31.41K SEK |
| Shares Outstanding | 33.72M |
| Float | 27.66M |
| Short Ratio | N/A |
| % Held by Insiders | 22.69% |
| % Held by Institutions | 31.71% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -38.94% |
| Return on Equity (ttm) | -65.57% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -151916000 SEK |
| Net Income Avi to Common (ttm) | -139367008 SEK |
| Diluted EPS (ttm) | -3.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 111.37M SEK |
| Total Cash Per Share (mrq) | 3.19 SEK |
| Total Debt (mrq) | 1.81M SEK |
| Total Debt/Equity (mrq) | 1.25 SEK |
| Current Ratio (mrq) | 3.491 |
| Book Value Per Share (mrq) | 4.149 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -131427000 SEK |
| Levered Free Cash Flow (ttm) | -79116248 SEK |
Profile of Ascelia Pharma AB (publ)
| Country | Sweden |
| State | N/A |
| City | Malmö |
| Address | Hyllie Boulevard 34 |
| ZIP | 215 32 |
| Phone | 46 7 35 17 91 18 |
| Website | https://www.ascelia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 24 |
Ascelia Pharma AB (publ), a biotech company, focuses on orphan oncology treatments in Sweden. It has two drug candidates in clinical development, which include Orviglance, a novel non-gadolinium diagnostic drug, which is in Phase 3 trial for use in MRI-scans of the liver; and Oncoral, a novel oral irinotecan chemotherapy tablet, which is in Phase 2 trial for the treatment of gastric cancer. The company was incorporated in 1999 and is headquartered in Malmö, Sweden.
Q&A For Ascelia Pharma AB (publ) Stock
What is a current ACE.ST stock price?
Ascelia Pharma AB (publ) ACE.ST stock price today per share is 9.44 SEK.
How to purchase Ascelia Pharma AB (publ) stock?
You can buy ACE.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ascelia Pharma AB (publ)?
The stock symbol or ticker of Ascelia Pharma AB (publ) is ACE.ST.
Which industry does the Ascelia Pharma AB (publ) company belong to?
The Ascelia Pharma AB (publ) industry is Biotechnology.
How many shares does Ascelia Pharma AB (publ) have in circulation?
The max supply of Ascelia Pharma AB (publ) shares is 33.76M.
What is Ascelia Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Ascelia Pharma AB (publ) PE Ratio is now.
What was Ascelia Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Ascelia Pharma AB (publ) EPS is -2.66 SEK over the trailing 12 months.
Which sector does the Ascelia Pharma AB (publ) company belong to?
The Ascelia Pharma AB (publ) sector is Healthcare.
Ascelia Pharma AB (publ) ACE.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 365.88 DKK 53.65 USD |
-0.2
|
— — | 365.8 DKK 53.63 USD | 366.99 DKK 53.81 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2732.06 SEK 266.68 USD |
-1.5
|
— — | 2732.06 SEK 266.68 USD | 2771.68 SEK 270.55 USD | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4524.33 SEK 441.63 USD |
-1
|
— — | 4524.33 SEK 441.63 USD | 4581.2 SEK 447.18 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 7565.06 SEK 738.44 USD |
-0.81
|
— — | 7565.06 SEK 738.44 USD | 7565.06 SEK 738.44 USD | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 636.84 SEK 62.16 USD |
+0.59
|
— — | 633.21 SEK 61.81 USD | 638.3 SEK 62.31 USD | — - | — — |
| OMX Stockholm_GI OMXSGI | 487.13 SEK 47.55 USD |
-1.49
|
— — | 487.13 SEK 47.55 USD | 493.17 SEK 48.14 USD | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 452.77 SEK 44.2 USD |
+0.24
|
— — | 451.78 SEK 44.1 USD | 453.92 SEK 44.31 USD | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 365.72 EUR 399.78 USD |
-0.2
|
— — | 365.63 EUR 399.69 USD | 366.81 EUR 400.97 USD | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 956.49 SEK 93.37 USD |
-1.49
|
— — | 956.49 SEK 93.37 USD | 968.23 SEK 94.51 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4397.78 SEK 429.28 USD |
-1.5
|
— — | 4397.78 SEK 429.28 USD | 4461.56 SEK 435.5 USD | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3511.58 SEK 342.77 USD |
-1
|
— — | 3511.58 SEK 342.77 USD | 3555.71 SEK 347.08 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5573.44 SEK 544.04 USD |
-0.81
|
— — | 5573.44 SEK 544.04 USD | 5573.44 SEK 544.04 USD | — - | — — |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1262.91 SEK 123.28 USD |
+0.59
|
— — | 1255.7 SEK 122.57 USD | 1265.8 SEK 123.56 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 980.59 SEK 95.72 USD |
-1.49
|
— — | 980.59 SEK 95.72 USD | 992.75 SEK 96.9 USD | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 477.13 SEK 46.57 USD |
-1.49
|
— — | 477.13 SEK 46.57 USD | 483.05 SEK 47.15 USD | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 538.42 ISK 3.96 USD |
-0.06
|
— — | 537.03 ISK 3.95 USD | 539.51 ISK 3.97 USD | — - | — — |
- {{ link.label }} {{link}}